μ-Conotoxin GIIIB

Arg-Asp-Cys-Cys-Thr-Hyp-Hyp-Arg-Lys-Cys-Lys-Asp-Arg-Arg-Cys-Lys-Hyp-Met-Lys-Cys-Cys-Ala-NH₂ (Disulfide bonds between Cys³-Cys¹⁵, Cys⁴-Cys²⁰, and Cys¹⁰-Cys²¹)
: (M.W. 2640.2) C₁₀₁H₁₇₅N₃₉O₃₀S₇
: Na⁺ Channel Blocker: Specific for Skeletal Muscle

Package	Price(Yen)	Availability	Quantity
Vial 0.5 mg	38,000	Ships within 1-3 business days
バルク見積もり

Solubility: H₂O (0.1 mM)

S. Sato, H. Nakamura, Y. Ohizumi, J. Kobayashi, and Y. Hirata, FEBS Lett., 155, 277 (1983). (Original)
L.J. Cruz, W.R. Gray, B.M. Olivera, R.D. Zeikus, L. Kerr, D. Yoshikami, and E. Moczydlowski, J. Biol. Chem., 260, 9280 (1985). (Naming)
Y. Ohizumi, H. Nakamura, J. Kobayashi, and W.A. Catterall, J. Biol. Chem., 261, 6149 (1986). (Pharmacol.)
S. Kubo, N. Chino, T.X. Watanabe, T. Kimura, and S. Sakakibara, Pept. Res., 6, 66 (1993). (Chem. Synthesis & Pharmacol.)
B.M. Olivera,W.R. Gray, R. Zeikus, J.M. McIntosh, J. Varga, J. Rivier, V. De Santos, and L.J. Cruz, Science, 230, 1338 (1985). (Review)
W.R. Gray, B.M. Olivera, and L.J. Cruz, Annu. Rev. Biochem., 57, 665 (1988). (Review)
R.A. Myers, L.J. Cruz, J.E. Rivier, and B.M. Olivera, Chem. Rev., 93, 1923 (1993). (Review)
B.M. Olivera, G.P. Miljanich, J. Ramachandran, and M.E. Adams, Annu. Rev. Biochem., 63, 823 (1994). (Review)